22 Nw, LP Anebulo Pharmaceuticals, Inc. Call Options Transaction History
22 Nw, LP
- $88.5 Million
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ANEB
# of Institutions
14Shares Held
7.34MCall Options Held
0Put Options Held
0-
Lvw Advisors, LLC641KShares$935,9160.16% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT511KShares$746,1660.06% of portfolio
-
Morgan Stanley New York, NY399KShares$582,8590.0% of portfolio
-
Ikarian Capital, LLC Dallas, TX158KShares$230,4780.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA154KShares$224,8920.0% of portfolio
About Anebulo Pharmaceuticals, Inc.
- Ticker ANEB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,633,200
- Market Cap $37.4M
- Description
- Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid intoxication and overdose. The ...